United Acquisition Corp. I Launches $100M SPAC IPO

TL;DR

**Avoid this SPAC; the significant dilution from founder shares and private placements makes it a risky bet for public shareholders.**

AI Summary

United Acquisition Corp. I (UAC-WT), a newly organized SPAC, is launching an initial public offering of 10,000,000 units at $10.00 per unit, aiming to raise $100,000,000. Each unit comprises one Class A ordinary share and one-quarter of one redeemable warrant. The company's primary goal is to complete a business combination within 24 months of the offering's close, with no specific target identified yet. The Sponsor, United Acquisition SPAC LLC, purchased 3,833,333 Class B ordinary shares for $25,000 and will acquire 2,333,333 private placement warrants for $0.75 each and 175,000 private placement units for $10.00 each, totaling $3,500,000. Chardan Capital Markets, LLC, the underwriter, will also purchase 100,000 private placement units for $1,000,000. A significant risk is the potential for material dilution to public shareholders due to the anti-dilution rights of Class B ordinary shares and the conversion of working capital loans into units at $10.00 each, up to $1,500,000. The company will deposit $100,000,000 from the offering into a trust account, with $5,000,000 allocated for underwriting discounts.

Why It Matters

This S-1 filing signals the entry of a new SPAC, United Acquisition Corp. I, into a competitive market, aiming to raise $100 million for an unspecified business combination. For investors, the blank-check nature presents both opportunity and significant risk, particularly with potential dilution from founder shares and private placements. Employees and customers of a future target company could see changes in ownership and strategic direction. The broader market will watch to see if this SPAC can successfully identify and merge with a high-growth private company, adding to the ongoing SPAC trend.

Risk Assessment

Risk Level: high — The risk level is high due to several factors: the anti-dilution provisions for Class B ordinary shares could result in material dilution to public shareholders' equity interests, and up to $1,500,000 in working capital loans may convert into units at $10.00 each, further diluting public shareholders. Additionally, the founder shares were purchased for approximately $0.009 per share, creating a strong incentive for the Sponsor to complete a transaction even if it's unprofitable for public shareholders.

Analyst Insight

Investors should exercise extreme caution and thoroughly evaluate the potential for significant dilution before considering an investment in UAC-WT. Given the substantial anti-dilution rights and low cost basis for founder shares, it would be prudent to wait until a definitive business combination target is identified and its terms are fully disclosed.

Financial Highlights

revenue

$0

total Assets

$100,000,000

total Debt

$0

net Income

$0

eps

$0.00

cash Position

$100,000,000

revenue Growth

N/A

Key Numbers

• $100,000,000 — Gross proceeds from IPO (Amount to be raised from the offering of 10,000,000 units at $10.00 each.)
• 10,000,000 — Units offered in IPO (Number of units being sold to the public, each consisting of one Class A ordinary share and one-quarter of one redeemable warrant.)
• $10.00 — Offering price per unit (The price at which each unit is sold to the public.)
• $5,000,000 — Underwriting Discount (Total underwriting discount, including $1,500,000 payable upon closing and up to $3,500,000 deferred.)
• 24 months — Time to complete business combination (The maximum period United Acquisition Corp. I has to complete its initial business combination from the closing of the offering.)
• 3,833,333 — Class B ordinary shares outstanding (Number of founder shares held by the Sponsor and independent directors, representing 25% of outstanding ordinary shares post-IPO.)
• $0.009 — Per-share purchase price of founder shares (The price paid by the Sponsor for Class B ordinary shares, highlighting a significant valuation disparity.)
• $1,750,000 — Sponsor's private placement investment (Aggregate amount the Sponsor will pay for private placement warrants and units.)
• $1,000,000 — Underwriter's private placement investment (Aggregate amount Chardan Capital Markets, LLC will pay for private placement units.)
• $1,500,000 — Maximum convertible working capital loans (Amount of loans from Sponsor, officers, directors, or affiliates that may convert into units, potentially diluting public shareholders.)

Key Players & Entities

• United Acquisition Corp. I (company) — Registrant and SPAC
• United Acquisition SPAC LLC (company) — Sponsor of the SPAC
• Chardan Capital Markets, LLC (company) — Underwriter for the IPO
• Paul Packer (person) — Chief Executive Officer of United Acquisition Corp. I
• Mario Schollmeyer (person) — Counsel from Sullivan & Cromwell LLP
• David Bulley (person) — Counsel from Appleby
• Christian O. Nagler, P.C. (person) — Counsel from Kirkland & Ellis LLP
• Continental Stock Transfer & Trust Company (company) — Trustee for the Trust Account
• U.S. Securities and Exchange Commission (regulator) — Regulatory body for the S-1 filing
• New York Stock Exchange (company) — Intended listing venue for UAC-WT securities

FAQ

Risk Factors

• Dilution from Sponsor Shares and Warrants [high — financial]: The Sponsor purchased 3,833,333 Class B ordinary shares for $25,000, or approximately $0.007 per share. These shares are convertible into Class A ordinary shares on a 1:1 basis. Additionally, the Sponsor will purchase 2,333,333 private placement warrants. This significant stake and warrant coverage held by the Sponsor creates a substantial risk of dilution for public shareholders upon a business combination.
• Dilution from Working Capital Loans [medium — financial]: The company may receive working capital loans from its Sponsor, officers, directors, or their affiliates, which can be convertible into units at $10.00 per unit, up to a maximum of $1,500,000. This conversion mechanism allows for the issuance of up to 150,000 units (1,500,000 / $10.00) at a price potentially lower than the market price at the time of conversion, leading to dilution for existing shareholders.
• SPAC Structure and Redemption Risk [medium — financial]: As a SPAC, UAC-WT's primary goal is a business combination within 24 months. If a combination is not consummated, public shareholders have the right to redeem their shares for their pro rata portion of the trust account. This redemption feature can significantly reduce the capital available for a target company, potentially impacting the deal structure and valuation.
• Underwriter's Private Placement Investment [low — financial]: Chardan Capital Markets, LLC, the underwriter, will purchase 100,000 private placement units for $1,000,000. While this provides capital, the underwriter's dual role as underwriter and private placement investor could present conflicts of interest.
• Lack of Identified Target [high — operational]: United Acquisition Corp. I has not yet identified a specific business combination target. This lack of a defined strategy introduces uncertainty regarding the future direction and success of the company, as the management team will be evaluating potential targets within a limited 24-month timeframe.
• SPAC Regulatory Scrutiny [medium — regulatory]: SPACs are facing increased regulatory scrutiny from bodies like the SEC. Changes in regulations or interpretations could impact the structure, valuation, and completion of business combinations, potentially affecting UAC-WT's ability to execute its strategy.

Industry Context

The SPAC market has experienced significant growth and subsequent contraction, with increased regulatory scrutiny. Companies like United Acquisition Corp. I operate in a competitive landscape where identifying and executing a successful business combination within the mandated timeframe is challenging. The current environment requires SPACs to demonstrate clear value propositions and robust due diligence to attract quality targets and satisfy investors.

Regulatory Implications

The S-1 filing indicates potential regulatory risks associated with SPACs, including increased SEC oversight and evolving disclosure requirements. The conversion of working capital loans and the structure of sponsor shares/warrants are areas that may attract regulatory attention regarding fairness and dilution to public investors.

What Investors Should Do

1. Analyze Sponsor Dilution
2. Evaluate Target Identification Risk
3. Understand Working Capital Loan Conversion
4. Monitor Underwriting and Sponsor Alignment

Glossary

SPAC

Special Purpose Acquisition Company. A shell company that raises capital through an IPO to acquire or merge with an existing company. (United Acquisition Corp. I is a newly organized SPAC aiming to complete a business combination.)

Units

A security consisting of multiple components, typically one ordinary share and a fraction of a warrant in a SPAC IPO. (The IPO offers 10,000,000 units, each comprising one Class A ordinary share and one-quarter of a redeemable warrant.)

Redeemable Warrants

Options that give the holder the right to purchase shares of the company's stock at a specified price within a certain timeframe. (Each unit includes a fraction of a warrant, providing potential upside for investors but also future dilution.)

Sponsor

The entity or individuals who organize and fund a SPAC, typically receiving founder shares and private placement warrants in exchange for their initial investment. (United Acquisition Corp. I's Sponsor, United Acquisition SPAC LLC, has significant share and warrant holdings.)

Class B Ordinary Shares

Shares typically held by the SPAC sponsor, often with different voting rights or conversion terms compared to Class A shares. (The Sponsor holds 3,833,333 Class B ordinary shares, which are convertible into Class A shares and carry anti-dilution provisions.)

Private Placement Warrants

Warrants purchased by the sponsor or other select investors concurrently with the IPO, often at a lower price than public warrants. (The Sponsor and underwriter are purchasing private placement warrants and units, impacting their cost basis and potential returns.)

Business Combination

The acquisition or merger of the SPAC with an operating company, which is the primary objective of a SPAC. (UAC-WT has 24 months to complete a business combination; failure to do so results in liquidation.)

Trust Account

An account where the proceeds from a SPAC's IPO are held in trust, typically invested in U.S. Treasury securities, until a business combination is completed or the SPAC liquidates. ($100,000,000 from the IPO will be deposited into the trust account.)

Year-Over-Year Comparison

As this is an S-1 filing for a newly organized SPAC, there is no prior filing to compare financial metrics against. Key figures such as revenue, net income, and margins are currently $0, as the company has not yet completed a business combination or generated operating revenue. The primary focus is on the capital raised ($100,000,000 IPO proceeds) and the structure of the offering, including sponsor economics and potential dilution risks.

Key Financial Figures

• $100,000,000 — TO COMPLETION, DATED DECEMBER 2, 2025 $100,000,000 United Acquisition Corp. I 10,000,0
• $10.00 — 0,000,000 units at an offering price of $10.00 each. Each unit consists of one Class A
• $11.50 — ne Class A ordinary share at a price of $11.50 per share, subject to adjustment as des
• $5,000,001 — t tangible asset condition, such as the $5,000,001 net tangible asset requirement. As such
• $1,000,000 — in full) at a price of $10.00 per unit ($1,000,000 in the aggregate (or $1,150,000 if the
• $1,150,000 — r unit ($1,000,000 in the aggregate (or $1,150,000 if the over-allotment is exercised in f
• $1,500,000 — sed to repay such loaned amounts. Up to $1,500,000 of such loans may be convertible into a
• $100,000 — ithdrawals, as defined below, and up to $100,000 of interest to pay dissolution expenses
• $500,000 — nts, which amount will be the lesser of $500,000 or 5% of the annual interest earned on
• $0.15 — 0,000 $ 95,000,000 (1) Including (A) $0.15 per unit sold in the offering, or $1,50
• $1,725,000 — ing, or $1,500,000 in the aggregate (or $1,725,000 if the underwriter's over-allotment opt
• $0.10 — hich the underwriter has committed that $0.10 per unit will be used by the underwrite
• $0.35 — e private placement units and (B) up to $0.35 per unit sold in the offering, or up to
• $3,500,000 — per unit sold in the offering, or up to $3,500,000 in the aggregate (or up to $4,025,000 i
• $4,025,000 — o $3,500,000 in the aggregate (or up to $4,025,000 if the underwriter's over-allotment opt

Filing Documents

• forms-1.htm (S-1) — 2800KB
• ex1-1.htm (EX-1.1) — 287KB
• ex3-1.htm (EX-3.1) — 425KB
• ex3-2.htm (EX-3.2) — 527KB
• ex4-1.htm (EX-4.1) — 28KB
• ex4-2.htm (EX-4.2) — 27KB
• ex4-3.htm (EX-4.3) — 30KB
• ex4-4.htm (EX-4.4) — 114KB
• ex5-1.htm (EX-5.1) — 11KB
• ex5-2.htm (EX-5.2) — 106KB
• ex10-1.htm (EX-10.1) — 61KB
• ex10-2.htm (EX-10.2) — 58KB
• ex10-3.htm (EX-10.3) — 79KB
• ex10-4.htm (EX-10.4) — 76KB
• ex10-5.htm (EX-10.5) — 146KB
• ex10-6.htm (EX-10.6) — 146KB
• ex10-7.htm (EX-10.7) — 145KB
• ex10-8.htm (EX-10.8) — 14KB
• ex14.htm (EX-14) — 52KB
• ex23-1.htm (EX-23.1) — 3KB
• ex99-1.htm (EX-99.1) — 90KB
• ex99-2.htm (EX-99.2) — 52KB
• ex99-3.htm (EX-99.3) — 48KB
• ex99-4.htm (EX-99.4) — 3KB
• ex99-5.htm (EX-99.5) — 5KB
• ex99-6.htm (EX-99.6) — 3KB
• ex99-7.htm (EX-99.7) — 3KB
• ex99-8.htm (EX-99.8) — 50KB
• ex107.htm (EX-FILING FEES) — 52KB
• ex5-2_001.jpg (GRAPHIC) — 7KB
• 0001493152-25-025837.txt ( ) — 7773KB
• uaci-20251202.xsd (EX-101.SCH) — 10KB
• uaci-20251202_def.xml (EX-101.DEF) — 18KB
• uaci-20251202_lab.xml (EX-101.LAB) — 66KB
• uaci-20251202_pre.xml (EX-101.PRE) — 60KB
• forms-1_htm.xml (XML) — 426KB
• ex107_htm.xml (XML) — 10KB

Underwriting

Underwriting Discount (1) Proceeds, Before Expenses, to us Per Unit $ 10.00 $ 0.50 $ 9.50 Total $ 100,000,000 $ 5,000,000 $ 95,000,000 (1) Including (A) $0.15 per unit sold in the offering, or $1,500,000 in the aggregate (or $1,725,000 if the underwriter's over-allotment option is exercised in full), payable to the underwriter upon the closing of this offering, of which the underwriter has committed that $0.10 per unit will be used by the underwriter to purchase private placement units and (B) up to $0.35 per unit sold in the offering, or up to $3,500,000 in the aggregate (or up to $4,025,000 if the underwriter's over-allotment option is exercised in full) is payable to the underwriter in this offering based on the percentage of funds remaining in the trust account after redemptions of public shares, for deferred underwriting commissions to be placed in a trust account located in the United States and released to the underwriter only upon the completion of an initial business combination. The table and this description do not include certain other agreed upon terms regarding the underwriter's compensation and certain reimbursements agreed to by the underwriter. See " Underwriting " for additional information regarding underwriting compensation. Of the proceeds we receive from this offering and the sale of the private securities, $100,000,000 or $115,000,000 if the underwriter's over-allotment option is exercised in full ($10.00 per unit), will be deposited into a segregated trust account located in the United in this prospectus, these funds will not be released to us until the earlier of (1) the completion of our initial business combination, (2) the redemption of any public shares properly submitted for redemption in connection with a shareholder vote to amend our amended and restated memorandum and articles of association (A)

Dilution

Dilution 86 Capitalization 88 Management's Discussion and Analysis of Financial Condition and Results of Operations 89 Proposed

Business

Business 93 Management 125 Principal Shareholders 135 Certain Relationships and R

View Full Filing

View this S-1 filing on SEC EDGAR